Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.
An oncologist explains the situations when doctors recommend getting screened for colorectal cancer before age 45.
The Company Reported 73% Clinical Clearance in the 200-µg cohort at Day 57PHILADELPHIA, March 09, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a ...
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results